Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Athanasios, Papaefstathiou"'
Autor:
Ioannis Antonakos, Kyriakos Souliotis, Theodora Psaltopoulou, Yannis Tountas, Athanasios Papaefstathiou, Maria Kantzanou
Publikováno v:
Medicines, Vol 8, Iss 8, p 42 (2021)
Background: Safety culture is considered one of the most crucial premises for further development of patient care in healthcare. During the eight-year economic crisis (2010–2018), Greece made significant reforms in the way the primary health care s
Externí odkaz:
https://doaj.org/article/58f9c0fbb7bd482794702803b42e182e
Autor:
Melpomeni Peppa, Albert Missbichler, Maria N. Dimopoulou, Ioannis Ntanasis-Stathopoulos, Ersi Voskaridou, Nikolaos Kanellias, Evangelos Terpos, Athanasios Papaefstathiou, Konstantina Repa, Dimitrios Christoulas, Athanasios Papatheodorou, Gerhard Hawa, Linda Sonnleitner
Publikováno v:
Hematology. 24:318-324
Noggin is an antagonist of bone morphogenetic proteins (BMPs) and has a strong effect on osteogenesis. Osteoporosis is a common complication of transfusion dependent beta-thalassemia (TDT) and denosumab has been recently emerged as a promising therap
Autor:
Maria Kantzanou, Athanasios Papaefstathiou, Theodora Psaltopoulou, Ioannis Antonakos, Kyriakos Souliotis, Yannis Tountas
Publikováno v:
Medicines, Vol 8, Iss 42, p 42 (2021)
Medicines
Volume 8
Issue 8
Medicines
Volume 8
Issue 8
Background: Safety culture is considered one of the most crucial premises for further development of patient care in healthcare. During the eight-year economic crisis (2010–2018), Greece made significant reforms in the way the primary health care s
Autor:
Dimitrios Christoulas, Ersi Voskaridou, Melpomeni Peppa, Evangelos Terpos, Athanasios Papaefstathiou, Maria N. Dimopoulou, Konstantina Repa, Ioannis Ntanasis-Stathopoulos, Athanasios Papatheodorou
Publikováno v:
Blood advances. 2(21)
Denosumab (DNM) is a fully human monoclonal antibody against the receptor activator of nuclear factor kappa-B ligand (RANKL) that has been licensed for the treatment of different types of osteoporosis. However, the prospective data for the evaluation
Autor:
Dario Boschiero, Charikleia Stefanaki, George Dimitriadis, George P. Chrousos, Athanasios Papaefstathiou, Melpomeni Peppa
Publikováno v:
HORMONES. 16
BACKGROUND-OBJECTIVES: We aimed at evaluating the efficiency of a newly developed, advanced Bioimpedance Analysis (BIA-ACC®) device as a screening tool for determining the degree of obesity and osteosarcopenia in postmenopausal women with normal or
Autor:
George P. Chrousos, Maria Karantza, Chryssa Bakoula, Helen N. Soultanakis, Polixeni Nikolaidou, Athanasios Papaefstathiou, Maria Papaefthymiou, Aikaterini Sarra
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 26
OBJECTIVE: To study bone density in healthy Greek girls going through puberty and determine the influence of developmental and hormonal factors. DESIGN: Sixty healthy female adolescents (average age of 13.88±2.53 years) were included. Bone mineral d
Autor:
Melpomeni, Peppa, Chrysi, Koliaki, Athanasios, Papaefstathiou, Efstathios, Garoflos, Nicholas, Katsilambros, Sotirios A, Raptis, Dimitrios I, Hadjidakis, George D, Dimitriadis
Publikováno v:
Obesity (Silver Spring, Md.). 21(9)
Although obesity is typically associated with increased cardiovascular risk, a subset of obese individuals display a normal metabolic profile ("metabolically healthy obese," MHO) and conversely, a subset of nonobese subjects present with obesity-asso
Autor:
George Dimitriadis, Nicholas Katsilambros, Dimitrios Hadjidakis, Sotirios A. Raptis, Eleni Boutati, Athanasios Papaefstathiou, Melpomeni Peppa, Efstathios Garoflos, Chrysi Koliaki
Publikováno v:
European Journal of Internal Medicine. 22:S49